Life

Bridging the Gap: MAHA and Public Health in Dialogue

The podcast 'Why Should I Trust You?' emphasizes the need for communication between MAHA and public health, highlighting the stakes involved.

Editorial Staff Apr 18

Mixed Feelings Surround Trump's CDC Appointment Amid RFK Jr. Concerns

While there is a sense of optimism regarding Trump's choice for the CDC, employees express a cautious outlook, especially concerning RFK Jr.'s involvement.

Editorial Staff Apr 18

Understanding the Kemp-Kasten Amendment and Its Impact on UNFPA Funding

This overview explores the Kemp-Kasten amendment, which restricts U.S. funding to organizations like the UNFPA that may be linked to coercive abortion or involuntary sterilization.

Promising Advances in Pancreatic Cancer Treatment Discussed by Expert

Paul Oberstein from NYU Langone's Perlmutter Cancer Center suggests that recent developments in pancreatic cancer treatment could signify a major shift in medical approaches.

Exploring Trends in Employer-Sponsored Health Insurance Coverage

A recent analysis sheds light on employer-based health insurance trends, revealing that 165.6 million individuals under 65 are covered.

FDA Considers Broader Testosterone Therapy for Enhancing Libido

The FDA is reportedly looking into the possibility of expanding testosterone therapy options, particularly for addressing libido issues, as new research emerges.

Examining the Risks of ICE Detention: New Insights

Recent research sheds light on the potential dangers associated with ICE detention, alongside discussions on GLP-1s and vaccine skepticism in health news.

Insights into Lilly's Weight Loss Pill and U.K. Clinical Trials

Recent findings on Lilly's weight loss pill trials and advancements in U.K. clinical trials highlight evolving perspectives on obesity treatment.

Pre-Transplant Cell Therapy Shows Promise for Liver Transplant Patients

A recent small study suggests that pre-transplant cell therapy may enable some liver transplant patients to discontinue the use of immunosuppressive drugs, indicating a potential shift in treatment approaches.

Understanding Vaccine Trust: A Closer Look at Recent Polls

Recent headlines may suggest a growing skepticism towards vaccines among Americans, but a new poll indicates that this perception may not reflect reality.

The Vulnerability of Health Care to AI-Driven Cyber Threats

As cyberattacks on health care systems escalate, the potential for patient harm grows. Andrea Downing highlights the urgent need for improved defenses against these threats.

HaloMD’s Legal Victory Sheds Light on Arbitration Challenges

A recent ruling provides important insights into navigating issues related to the No Surprises Act, particularly regarding arbitration decisions.

Editorial Staff Apr 16

Current Trends in MAHA: Breakthroughs and Challenges

Recent updates on MAHA highlight a significant breakthrough in Duchenne muscular dystrophy, alongside ongoing challenges in cancer treatment and other health developments.

Editorial Staff Apr 8

Reviving Hope: A Mother's Fight for Neuromuscular Drug Class

A mother's determination has reignited interest in a neglected class of drugs, potentially benefiting her son and many others with neuromuscular disorders.

Editorial Staff Apr 8

Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review

A federal judge Tuesday refused to block filling prescriptions for the abortion pill mifepristone by mail across the U.S. — at least for now.

Editorial Staff Apr 8

Tracking Key Mental Health and Substance Use Policy Actions Under the Trump Administration

Strategic angle: A new KFF tracker highlights key federal policy actions during President Trump’s second term that concern issues related to mental health and substance use.

KFF Tracker: America First MOU Bilateral Global Health Agreements

Strategic angle: This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements with the U.S.

Novo Nordisk launches high-dose Wegovy

Strategic angle: Insurers score Medicare Advantage wins, the obesity drug race continues, and other biotech news from The Readout.

Measles Elimination Status: What It Is and How the U.S. Could Lose It

Strategic angle: This policy watch examines the United States’ measles elimination status and the potential threats to it.